On top of “business-as-usual”, company leaders must face very complex and uncertain geopolitical and macroeconomic challenges, particularly for global companies. Some of the macroeconomic uncertainties these leaders have to overcome are inflation, rising interest rates, and fear of recession. Businesses also have to deal with the diversification of its supply chains and potential relocation of manufacturing plants, energy supply restrictions and cybersecurity risks, while reaching its business, equity and sustainability goals. Join us to hear from MIT faculty and MIT Startup Exchange entrepreneurs to learn about their views on how to deal with some of these pressing issues, lead creatively and innovate in times of uncertainty.
Tata Steel, a leading Industrial Steel Producer, is Looking for Particulate Emissions Reduction Solutions. It's interested in technologies for particulate matter control (PM 10 and PM 2.5) for outdoor environments.
Syngenta, a Global $13B company that produces agrochemicals and seeds, Looking for sources of dietary protein as an alternative to conventional food production
Takeda is looking for new approaches and technologies that can help them address challenges/opportunities in gastroenterology, oncology, neuroscience and rare genetic & hematology.
Organizations and individuals are facing tremendous challenges in today’s workplace. How work gets done, when and where work gets done and now who does the work are key questions that leaders have to tackle. In this symposium we will address the impact of Artificial Intelligence on the future of work. How can new technology tools like generative AI improve productivity and product quality for firms, as well as flexibility and job quality for workers? How can we tackle workforce development in new ways to gear up for this paradigm shift in the workplace?
OPmobility to explore with select startups the opportunity for joint development, proof of concept or pilot then commercial usage.
Discovering new molecules faster with AI
Startup Lightning Talks - 2022 MIT Health Science Technologies Conference The Future of Cell & Gene Therapies